1.07 (-3.75%)
As of Sep 07, 2023
Source:
Surface Oncology, Inc is a clinical-stage immuno-oncology company focused on using our specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment, or the TME, for the development of next-generation cancer therapies.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | 617-714-4096 |
Industry | manufacturing |
CEO | Robert W. Ross, M.D. |
Website | www.surfaceoncology.com |